Clozapine associated cardiomyopathy: A cluster of 3 cases

Internal and Emergency Medicine

Volumn 6, Issue 3, 2011, Pages 281-283

  Rostagno, Carlo ^a   Domenichetti, Sandro ^b   Pastorelli, Francesca ^a   Gensini, Gian Franco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONGESTIVE CARDIOMYOPATHY; HUMAN; LETTER; MALE;

ADULT; ANTIPSYCHOTIC AGENTS; CARDIOMYOPATHY, DILATED; CLOZAPINE; HUMANS; MALE;

EID: 79956318159     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0468-4     Document Type: Letter

References (5)

1. Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321: 1371-1376.
2. Haas SJ, Hill R, Krum H, Liew D et al (2007) Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Drug Saf 30: 47-57.
3. Leo RJ, Kreger JL, Kim KY (1996) Cardiomyopathy associated with clozapine. Ann Pharmacother 30: 603-605.
4. La Grenade L, Graham D, Trontell A (2001) Myocarditis and cardiomyopathy associated with clozapine in the United States. N Engl J Med 345: 224-225.
5. Rostagno C, Di Norscia G, Placidi GF, Gensini GF (2008) Beta-blocker and angiotensin-converting enzyme inhibitor may limit certain cardiac adverse effects of clozapine. Gen Hosp Psychiatry 30: 280-283.